Hyaluronidase, human
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyaluronidase, human, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]